GOVERNMENT COUNSEL, LLC

Lobbying for PRIME THERAPEUTICS · Pharmacy Benefit Management

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Minnesota · House · Senate · $30,000.00 income · posted Oct 2, 2025

Lobbying activity 2

Health Issues

H.R.2214-The DRUG Act.

Medicare/Medicaid

S. 891-The Bipartisan Health Care Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem